首页> 美国卫生研究院文献>Immunology >Altered expression and endocytic function of CD205 in human dendritic cells and detection of a CD205–DCL-1 fusion protein upon dendritic cell maturation
【2h】

Altered expression and endocytic function of CD205 in human dendritic cells and detection of a CD205–DCL-1 fusion protein upon dendritic cell maturation

机译:树突状细胞成熟后CD205在人树突状细胞中的表达和内吞功能发生改变并检测到CD205–DCL-1融合蛋白

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD205 (DEC-205) is a member of the macrophage mannose receptor family of C-type lectins. These molecules are known to mediate a wide variety of biological functions including the capture and internalization of ligands for subsequent processing and presentation by dendritic cells. Although its ligands await identification, the endocytic properties of CD205 make it an ideal target for those wishing to design vaccines and targeted immunotherapies. We present a detailed analysis of CD205 expression, distribution and endocytosis in human monocyte-derived dendritic cells undergoing lipopolysaccharide-induced maturation. Unlike other members of the macrophage mannose receptor family, CD205 was up-regulated upon dendritic cell maturation. This increase was a result of de novo synthesis as well as a redistribution of molecules from endocytic compartments to the cell surface. Furthermore, the endocytic capacity of CD205 was abrogated and small amounts of the recently identified CD205–DCL-1 fusion protein were detected in mature DC. Our results suggest that CD205 has two distinct functions – one as an endocytic receptor on immature dendritic cells and a second as a non-endocytic molecule on mature dendritic cells – and further highlight its potential as an immuno-modulatory target for vaccine and immunotherapy development.
机译:CD205(DEC-205)是C型凝集素的巨噬细胞甘露糖受体家族的成员。已知这些分子可介导多种生物学功能,包括捕获和内化配体,以供树突状细胞随后加工和呈递。尽管其配体尚待鉴定,但CD205的内吞特性使其成为希望设计疫苗和靶向免疫疗法的人们的理想靶标。我们目前进行的脂蛋白诱导的成熟人类单核细胞衍生的树突状细胞中CD205表达,分布和内吞作用的详细分析。与巨噬细胞甘露糖受体家族的其他成员不同,CD205在树突状细胞成熟时被上调。这种增加是从头合成以及分子从内吞区室到细胞表面的重新分布的结果。此外,CD205的内吞能力被废除,在成熟的DC中检测到少量的最近鉴定出的CD205-DCL-1融合蛋白。我们的结果表明,CD205具有两种不同的功能-一种作为未成熟树突状细胞上的内吞受体,另一种作为成熟树突状细胞上的非内吞分子-并进一步突显了其作为疫苗和免疫疗法开发的免疫调节靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号